Surgery for second lung cancers

被引:34
作者
Asaph, JW
Keppel, JF
Handy, JR
Douville, EC
Tsen, AC
Ott, GY
机构
[1] Oregon Clin, PC, Portland, OR 97213 USA
[2] Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR USA
关键词
CT; lung cancer; metachronous lung tumors;
D O I
10.1378/chest.118.6.1621
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: To evaluate the outcomes of patients surgically treated for their second primary lung cancer. Method: In a computerized surgical registry of > 800 consecutive patients treated for primary pulmonary carcinoma since 1980, 37 patients presented with a second lung cancer. These patients were analyzed regarding their original treatment, preoperative evaluation, operative procedures, and long-tem follow-up. Results: Three fifths of the patients were female, and 57% mere greater than or equal to 65 years old at the time of their second operation. One patient originally had two synchronous tumors; another patient had three metachronous neoplasms. The interval between surgeries ranged from 5 to 239 months. In 31 patients, treatment for their original tumor was surgical resection alone. Lobectomy was the most common operation for the original tumor, and 78% were stage I. When the second tumor was diagnosed, 25 patients (68%) were asymptomatic. Eight patients (22%) were current smokers, and 29 patients (78%) were former smokers. The most common operation for the second tumor was a lobectomy. Surgical mortality was 5.4%. Nineteen patients (51%) survived 2 years, and 9 patients (24%) survived greater than or equal to 5 years. Eleven patients (30%) were still alive at last follow-up, 3 to 198 months postoperatively, and only 13 patients (34%) had died of their cancer. Conclusion: Surgical treatment of second primary pulmonary neoplasms can be performed in selected patients with acceptable long-term survival.
引用
收藏
页码:1621 / 1625
页数:5
相关论文
共 16 条
[1]   The results of modern surgical therapy for multiple primary lung cancers [J].
Adebonojo, SA ;
Moritz, DM ;
Danby, CA .
CHEST, 1997, 112 (03) :693-701
[2]   2ND PRIMARY LUNG-CANCER [J].
ANTAKLI, T ;
SCHAEFER, RF ;
RUTHERFORD, JE ;
READ, RC .
ANNALS OF THORACIC SURGERY, 1995, 59 (04) :863-867
[3]  
DESCHAMPS C, 1990, J THORAC CARDIOV SUR, V99, P769
[4]   Early Lung Cancer Action Project: overall design and findings from baseline screening [J].
Henschke, CI ;
McCauley, DI ;
Yankelevitz, DF ;
Naidich, DP ;
McGuinness, G ;
Miettinen, OS ;
Libby, DM ;
Pasmantier, MW ;
Koizumi, J ;
Altorki, NK ;
Smith, JP .
LANCET, 1999, 354 (9173) :99-105
[5]  
JENSIK RJ, 1981, J THORAC CARDIOV SUR, V82, P658
[6]  
Johnson BE, 1997, SEMIN ONCOL, V24, P492
[7]   How tumor stage affects surgeons' surveillance strategies after lung cancer surgery [J].
Johnson, FE ;
Naunheim, KS ;
Coplin, MA ;
Virgo, KS .
CHEST, 1997, 111 (01) :99-102
[8]   PULMONARY RESECTION IN PATIENTS AFTER PNEUMONECTOMY [J].
KITTLE, CF ;
FABER, LP ;
JENSIK, RJ ;
WARREN, WH .
ANNALS OF THORACIC SURGERY, 1985, 40 (03) :294-299
[9]  
LEGAL Y, 1961, J THORAC CARDIOV SUR, V41, P114
[10]  
MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606